What can lawmakers do about the impact of record-high obesity rates on U.S systemic health care costs? GLP-1 products have been found to increase weight loss in some patients and may offer hope to manage the condition. But with concerns about the price of these drugs looming, how are legislators balancing these issues?
- Moderator: Colleen Becker, Project Manager, National Conference of State Legislatures
- Speaker: Josh Bolin, Senior Advisor, National Association of Boards of Pharmacy
- Speaker: Stacie B. Dusetzina, Professor, Health Policy, Vanderbilt University Medical Center